Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appMorphoSys shares are currently gaining nearly 37%.
Source: xStation
